NorMIGS - a Study of Micro-invasive Glaucoma Surgery
NorMIGS - a Prospective Study of Micro-invasive Glaucoma Surgery
Oslo University Hospital
100 participants
Apr 22, 2022
OBSERVATIONAL
Conditions
Summary
NorMIGS is a non-randomized clinical study of intraocular pressure lowering effect and complications after Preserflo microshunt implantation versus other types of glaucoma surgery. The study is conducted in the Department of Ophthalmology, Oslo University Hospital, Norway.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Implantation of Preserflo microshunt (Santen) to lower intraocular pressure
Trabeculectomy surgery to lower intraocular pressure
Other MIGS than Preserflo microshunt (e.g., XEN gel stent, iStent inject) to lower intraocular pressure
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05340647